Surfactant proteins A and D: Major factors of the immune response of the lung;Die surfactantproteine A und D: Wesentliche faktoren des pulmonalen abwehrsystems

Zeitschrift fur Geburtshilfe und Neonatologie

Volumn 207, Issue 2, 2003, Pages 41-47

  Kramer, Boris W ^a   Speer, C P ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Collectins; Pulmonary inflammation; Surfactant protein A and D

Indexed keywords

COLLAGEN; COLLECTIN; INTERLEUKIN 2; LECTIN; REACTIVE OXYGEN METABOLITE; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D;

AMNION FLUID; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; BINDING AFFINITY; CYTOKINE PRODUCTION; FETUS (ANATOMY); FUNGUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; INFECTION PREVENTION; LUNG; LYMPHOCYTE PROLIFERATION; MOLECULAR MECHANICS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PHAGOCYTOSIS; PREMATURITY; PROTECTION; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; STRUCTURE ANALYSIS; T LYMPHOCYTE; VIRUS;

EID: 0038180821     PISSN: 09482393     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-39152     Document Type: Review

References (74)

1. Speer CP, Halliday HL. Surfactant therapy in the newborn. Curr Pediatr 1994; 4: 5-9
2. Ikegami M, Jobe AH. Surfactant protein metabolism in vivo. Biochim Biophys Acta 1998; 1408: 218-25
3. Jobe AH, Ikegami M. Biology of surfactant. Clin Perinatol 2001; 28: 655-69
4. Baur FM, Brenner B, Goetze-Speer B, Neu S, Speer CP. Natural porcine surfactant (Curosurf) down-regulates mRNA of tumor necrosis factor-alpha (TNF-alpha) and TNF-alpha type 11 receptor in lipopolysaccharide-stimulated monocytes. Pediatr Res 1998; 44: 32-6
5. Speer CP, Götze B, Curstedt T, Robertson B. Phagocytic functions and tumor necrosis factor secretion of human monocytes exposed to natural porcine surfactant (Curosurf). Pediatr Res 1991; 30: 69-74
6. Speer CP, Robertson B, Halliday HL. Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant? Acta Paediatr 2000; 89: 510-2
7. Griese M. Pulmonary surfactant in health and human lung diseases: state of the art. Eur Respir J 1999; 13: 1455-76
8. Corcoran JD, Sheehan O, O'Hara MMT, Halliday HL. Tracheal surfactant protein-A following treatment with Curosurf. Appl Cardiopul Pathophysiol 1995; 5: 245-8
9. Hallman M, Merrittt TA, Akino T, Bry K. Surfactant protein-A, phosphatidylcholine, and surfactant inhibitors in epithelial lining fluid - correlation with surface activity, severity of respiratory distress syndrome, and outcome in small premature infants. Am Rev Respir Dis 1991; 144: 1376-84
10. Burri PW. Developmental and growth of the human lung. In: Fishman AP, Fisher AB, eds. Handbook of Physiology: The Respiratory System Bethesda, MD: American Physiologic Society, 1985: 1-46
11. Crouch E, Wright JR. Surfactant proteins A and D and pulmonary host defense. Annu Rev Physiol 2001; 63: 521-54
12. Narendran V, Wickett RP, Pickens WL, Hoath SB. Interaction between pulmonary surfactant and vernix: a potential mechanism for induction of amniotic fluid turbidity. Pediatr Res 2000; 48: 120-4
13. Hoeger PH, Enzmann CC. Skin physiology of the neonate and young infant: a prospective study of functional skin parameters during early infancy. Pediatr Dermatol 2002; 19: 256-62
14. Sullivan LC, Daniels CB, Phillips ID, Orgeig S, Whitsett JA. Conservation of surfactant protein A: evidence for a single origin for vertebrate pulmonary surfactant. J Mol Evol 1998; 46: 131-8
15. Perl AK, Whitsett JA. Molecular mechanisms controlling lung morphogenesis. Clin Genet 1999; 56: 14-27
16. Crouch EC. Modulation of host-bacterial interactions by collectins. Am J Respir Cell Mol Biol 1999; 21: 558-61
17. Crouch E, Hartshorn K, Ofek I. Collectins and pulmonary innate immunity. Immunol Rev 2000; 173: 52-65
18. Mariencheck WI, Savov J, Dong Q, Tino MJ, Wright JR. Surfactant protein A enhances alveolar macrophage phagocytosis of a live, mucoid strain of P. aeruginosa. Am J Physiol 1999; 277: L777-86
19. LeVine AM, Kurak KE, Wright JR, Watford WT, Bruno MD, Ross GF, Whitsett JA, Korfhagen TR. Surfactant protein-A (SP-A) binds group B streptococcus enhancing phagocytosis and clearance from lungs of surfactant protein-A deficient mice. Am J Respir Mol Cell Biol 1999; 20: 279-86
20. Ghildyal R, Hartley C, Varrasso A, Meanger J, Voelker DR, Anders EM, Mills J. Surfactant protein A binds to the fusion glycoprotein of respiratory syncytial virus and neutralizes virion infectivity. J Infect Dis 1999; 180: 2009-13
21. Patthy L. Is lung surfactant protein A lectin-collagen hybrid? Nature 1987; 325: 490
22. Wright JR, Wager RE, Hawgood S, Dobbs L, Clements JA. Surfactant apoprotein Mr = 26,000-36,000 enhances uptake of liposomes by type II cells. J Biol Chem 1987; 262: 2888-94
23. Wright JR. Immunomodulatory functions of surfactant. Physiol Rev 1997; 77: 931-62
24. Crouch EC. Collectins and pulmonary host defense. Am J Respir Cell Mol Biol 1998; 19: 177-201
25. van Iwaarden JF, Vanstrijp JAG, Visser H, Haagsman HP, Verhoef J, van Golde LMG. Binding of surfactant protein A (SP-A) to herpes simplexs virus Type 1-infected cells is mediated by the carbohydrate moiety of SP-A. J Biol Chem 1992; 267: 25039-43
26. Palaniyar N, Ikegami M, Korfhagen T, Whitsett J, McCormack FX. Domains of surfactant protein A that affect protein oligomerization, lipid structure and surface tension. Comp Biochem Physiol A Mol Physiol 2001; 129: 109-27
27. Rust K, Grosso L, Zhang V, Chang D, Persson A, Longmore W, Cai GZ, Crouch E. Human surfactant protein-D: SP-D contains a C-type lectin carbohydrate recognition domain. Arch Biochem Biophys 1991; 290: 116-26
28. Kabha K, Schmegner J, Keisari Y, Parolis H, Schlepper-Schaeffer J, Ofek I. SP-A enhances phagocytosis of Klebsiella by interaction with capsular polysaccharides and alveolar macrophages. Am J Physiol 1997; 272: L344-52
29. Sano H, Sohma H, Muta T, Momura S, Voelker DR, Kuroki Y. Pulmonary surfactant protein A modulates the cellular response to smooth and rough lipopolysaccharides by interaction with CD14. J Immunol 1999; 164: 387-95
30. van Rozendaal BA, van Spriel AB, van DeWinkel JG, Haagsman HP. Role of pulmonary surfactant protein D in innate defense against Candida albicans. J Infect Dis 2000; 182: 917-22
31. Restrepo CI, Dong Q, Savoy J, Mariencheck WI, Wright JR. Surfactant protein D stimulates phagocytosis of Pseudomonas aeruginosa by alveolar macrophages. Am J Respir Cell Mol Biol 1999; 21: 576-85
32. Madan T, Eggleton P, Kishore U, Strong P, Aggrawal SS, Sarma PU, Reid KBM. Binding of pulmonary proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages. Infect Immun 1997; 65: 3171-9
33. Hickling TP, Bright H, Wing K, Gower D, Martin SL, Sire RB, Malhotra R. A recombinant trimeric surfactant protein D carbohydrate recognition domain inhibits respiratory syncytial virus infection in vitro and in vivo. Eur J Immunol 1999; 29: 3478-84
34. Wright JR, Borron P, Brinker KG, Folz RJ. Surfactant Protein A: reguIation of innate and adaptive immune responses in lung inflammation. Am J Respir Cell Mol Biol 2001; 24: 513-7
35. Yang S, Milla C, Panoskaltsis-Mortari A, Ingbar DH, Blazar BR, Haddad IY. Human surfactant protein a suppresses T cell-dependent inflammation and attenuates the manifestations of idiopathic pneumonia syndrome in mice. Am J Respir Cell Mol Biol 2001; 24: 527-36
36. Borron P, Veldhuizen RAW, Lewis JE, Possmayer F, Caveney A, Inchiey K, Mcfadden RG, Fraher LJ. Surfactant associated protein-A inhibits human lymphocyte proliferation and IL-2 production. Am J Respir Cell Mol Biol 1996; 15: 115-21
37. Borron P, McCormack FX, Elhalwagi BM, Chroneos Z, Lewis JE Zhu S, Wright JR, Shephard VL, Possmayer F, Inchley K, Fraher LJ. Surfactant protein A inhibits T-cell proliferation via its collagen-like tail and a 210-kDa receptor. Am J Physiol Lung Cell Mol Physiol 1998; 275: L679-86
38. Borron PJ, Crouch EC, Lewis JF, Wright JR, Possmayer F, Fraher LJ. Recombinant rat surfactant-associated protein D inhibits human T lymphocyte proliferation and IL-2 production. J Immunol 1998; 161: 4599-603.
39. Wang JY, Shieh CC, You P-F, Lei H-Y, Reid KBM. Inhibitory effect of pulmonary surfactant proteins A and D on allergen-induced lymphocyte proliferation and histamine release in children with asthma. Am J Respir Crit Care Med 1998; 158: 510-8
40. Schelonka RL, Infante AJ. Neonatal immunology. Semin Perinatol 1998; 22: 2-14
41. Jobe AH, Ikegami M. Mechanisms initiating lung injury in the preterm. Early Hum Dev 1998; 53: 81-94
42. Speer CP, Johnston RB. Neutrophil function in newborn infants. In: Polin RA, Fox WW, eds. Fetal and neonatal physiology Philadelphia: W.B. Saunders, 1998: 1954-60
43. Stoll BJ, Holman RC, Schuchat A. Decline in sepsis-associated neonatal and infant death the United States, 1979 trough 1994. Pediatrics 1998; 102: e18
44. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, Lemons JA, Donovan EF, Stark AR; Tyson JE, Oh W, Bauer CR, Korones SB, Shankaran S, Laptook AR, Stevenson DK, Papile LA, Poole WK. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 2002; 347: 240-7
45. Honda Y, Takahashi H, Kuroki Y, Akino T, Abe S. Decreased contents of surfactant proteins A and D in BAL fluids of healthy smokers. Chest 1996; 109: 1006-9
46. Hawgood S, Ochs M, Jung A, Akiyama J, Allen L, Brown C, Edmondson J, Levitt S, Carlson E, Gillepsie AM, Villar A, Epstein CJ, Poulain FR. Sequential targeted deficiency of SP-A and -D leads to progressive alveolar lipoproteinosis and emphysema. Am J Physiol Lung Cell Mol Physiol 2002; 283: L1002-10
47. Baughman RP, Sternberg RI, Hull W, Buchsbaum JA, Whitsett J. Decreased surfactant protein-A in patients with bacterial pneumonia. Am Rev Respir Dis 1993; 147: 653-7
48. Greene KE, Wright JR, Steinberg KP, Ruzinski JT, Caldwell E, Wong WB, Hull W, Whitsett JA, Akino T, Kuroki Y, Nagae H, Hudson LD, Martin TR. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med 1999; 160: 1843-50
49. Hull J, South M, Phelan P, Grimwood K. Surfactant Composition in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 1997; 156: 161-5
50. Postle AD, Mander A, Reid KB, Wang JY, Wright SM, Moustaki M, Warner JO. Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis. Am J Respir Cell Mol Biol 1999; 20: 90-8
51. Meyer KC, Sharma A, Brown R, Weatherly M, Moya FR, Lewandoski J, Zimmermann JJ. Function and composition of pulmonary surfactant and surfactant-derived fatty acid profiles are altered in young adults with cystic fibrosis. Chest 2000; 118: 164-74
52. von Bredow C, Birrer P, Griese M. Surfactant protein A and other bronchoalveolar lavage fluid proteins are altered in cystic fibrosis. Eur Respir J 2001; 17: 716-22
53. Ratjen F, Doring G, Nikolaizik WH. Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis. Lancet 2001; 358: 983-4
54. Khubchandani KR, Oberley RE, Snyder JM. Effects of surfactant protein A and NaCl concentration on the uptake of Pseudomonas aeruginosa by THP-1 cells. Am J Respir Cell Mol Biol 2001; 25: 699-706
55. Korfhagen TR. Surfactant protein A (SP-A)-mediated bacterial clearance: SP-A and cystic fibrosis. Am J Respir Cell Mol Biol 2001; 25: 668-72
56. Korfhagen TR, Bruno MD, Ross GF, Huelsman KM, Ikegami M, Jobe AH, Wert SE, Stripp BR, Morris RE, Glasser SW, Bachurski CJ, Iwamoto HS, Whitsett JA. Altered surfactant function and strucute in SP-A gene targeted mice. Proc Natl Acad Sci USA 1996; 93: 9594-9
57. Korfhagen TR, Sheftelyevich V, Burhans MS, Bruno MD, Ross GF, Wert SE, Stahlman MT, Jobe AH, Ikegami M, Whitsett JA, Fisher JH. Surfactant protein-D regulates surfactant phospholipid homeostasis in vivo. J Biol Chem 1998; 43: 28438-43
58. Fisher JA, Sheftelyevich V, Ho Y-S, Fligiel S, McCormack FX, Korfhagen TR; Whitsett JA, Ikegami M. Pulmonary-specific expression of SP-D corrects pulmonary lipid accumulation in SP-D gene-targeted mice. Am J Physiol 2000; 278: L365-73
59. Botas C, Poulain F, Akiyama J, Brown C, Allen L, Goerke J, Clements J, Carlson E, Gillepsie AM, Epstein C, Hawgood S. Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D. Proc Natl Acad Sci USA 1998; 95: 11869-74
60. Ikegami M, Korfhagen TR, Bruno MD, Whitsett JA, Jobe AH. Surfactant metabolism in surfactant protein A-deficient mice. Amer J Physiol 1997; 272: L479-85
61. Ikegami M, Korfhagen TR, Whitsett JA, Bruno MD, Wert SE, Wada K, Jobe AH. Characteristics of surfactant from SP-A deficient mice. Am J Physiol 1998; 275: L247-58
62. Elhalwagi BM, Zhang M, Ikegami M, Iwamoto HS, Morris RE, Miller ML, Dienger K, McCormack FX. Normal surfactant pool sizes and inhibition-resistant surfactant from mice that overexpress surfactant protein A. Am J Respir Cell Mol Biol 1999; 21: 380-7
63. McCormack FX, Whitsett JA. The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J Clin Invest 2002; 109: 707-12
64. Ikegami M, Elhalwagi BM, Palaniyar N, Dienger K, Korfhagen T, Whitsett JA, McCormack FX. The collagen-like region of surfactant protein A (SP-A) is required for correction of surfactant structural and functional defects in the SP-A null mouse. J Biol Chem 2001; 276: 38542-8
65. Linke MJ, Harris CE; Korfhagen TR, McCormack FX, Ashbaugh AD, Steele P, Whitsett JA, Walzer PD. Immunosuppressed surfactant protein A-deficient mice have increased susceptibility to Pneumocystis carinii infection. J Infect Dis 2001; 183: 943-52
66. LeVine AM, Bruno MD, Huelsman KM, Ross GF, Whitsett JA, Korfhagen TR. Surfactant protein A-deficient mice are susceptible to group B streptococcal infection. J Immunol 1997; 158: 4336-40
67. LeVine AM, Kurak KE, Bruno MD, Stark J, Whitsett JA, Korfhagen TR. Surfactant protein-A-deficient mice are susceptible to pseudomonas aeruginosa infection. Am J Respir Mol Cell Biol 1998; 19: 700-8
68. LeVine AM, Gwozdz J, Stark J, Bruno MD, Whitsett JA, Korfhagen TR. Surfactant protein-A enhances respiratory syncytial virus clearance in vivo. J Clin Invest 1999; 103: 1015-21
69. Bridges JP, Davis HW, Damodarasamy M, Kuroki Y, Howles G, Hui DY, McCormack FX. Pulmonary surfactant proteins A and D are potent endogenous inhibitors of lipid peroxidation and oxidative cellular injury. J Biol Chem 2000; 275: 38848-55
70. Ikegami M, Whitsett JA, Jobe AH, Ross G, Fisher J, Korfhagen T. Surfactant metabolism in SP-D gene-targeted mice. Am J Physiol 2000; 279: L468-76
71. Wert SE, Yoshida M, LeVine AM, Ikegami M, Jones T, Ross GF, Fisher JH, Korfhagen TR, Whitsett JA. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. Proc Natl Acad Sci USA 2000; 97: 5972-7
72. LeVine AM, Whitsett JA; Hartshorn KL, Crouch EC, Korfhagen TR. Surfactant protein D enhances clearance of influenza A virus from the lung in vivo. J Immunol 2001; 167: 5868-73
73. LeVine AM, Whitsett JA, Gwozdz JA, Richardson TR, Fisher JH, Burhans MS, Korfhagen TR. Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung. J Immunol 2000; 165: 3934-40
74. Yoshida M, Korfhagen TR, Whitsett JA. Surfactant protein D regulates, NF-kappa B and matrix metalloproteinase production in alveolar macrophages via oxidant-sensitive pathways. J Immunol 2001; 166: 7514-9